L. Roy Papp & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-36,885
| Closed | -$6.09M | – | 175 |
|
|
2021
Q2 | $6.09M | Sell |
36,885
-4,186
| -10% | -$692K | 0.77% | 35 |
|
|
2021
Q1 | $6.3M | Sell |
41,071
-5,215
| -11% | -$800K | 0.9% | 34 |
|
|
2020
Q4 | $5.81M | Buy |
46,286
+593
| +1% | +$74.4K | 0.67% | 37 |
|
|
2020
Q3 | $4.64M | Sell |
45,693
-764
| -2% | -$77.5K | 0.6% | 40 |
|
|
2020
Q2 | $4.52M | Hold |
46,457
| – | – | 0.64% | 37 |
|
|
2020
Q1 | $3.86M | Buy |
46,457
+382
| +0.8% | +$31.7K | 0.7% | 39 |
|
|
2019
Q4 | $5.12M | Sell |
46,075
-37
| -0.1% | -$4.11K | 0.74% | 37 |
|
|
2019
Q3 | $4.58M | Buy |
46,112
+659
| +1% | +$65.4K | 0.72% | 38 |
|
|
2019
Q2 | $4.51M | Buy |
45,453
+337
| +0.7% | +$33.4K | 0.71% | 39 |
|
|
2019
Q1 | $4.98M | Sell |
45,116
-2,515
| -5% | -$277K | 0.9% | 31 |
|
|
2018
Q4 | $4.38M | Buy |
47,631
+896
| +2% | +$82.4K | 0.92% | 31 |
|
|
2018
Q3 | $5.15M | Buy |
46,735
+750
| +2% | +$82.6K | 0.92% | 30 |
|
|
2018
Q2 | $4.29M | Buy |
45,985
+2,630
| +6% | +$246K | 0.81% | 34 |
|
|
2018
Q1 | $3.6M | Buy |
43,355
+1,750
| +4% | +$145K | 0.69% | 39 |
|
|
2017
Q4 | $3.79M | Sell |
41,605
-1,249
| -3% | -$114K | 0.75% | 33 |
|
|
2017
Q3 | $3.26M | Buy |
42,854
+14,354
| +50% | +$1.09M | 0.71% | 38 |
|
|
2017
Q2 | $2.14M | Buy |
28,500
+9,773
| +52% | +$733K | 0.46% | 52 |
|
|
2017
Q1 | $1.22M | Buy |
18,727
+735
| +4% | +$48K | 0.28% | 68 |
|
|
2016
Q4 | $992K | Buy |
+17,992
| New | +$992K | 0.23% | 78 |
|